Bilimsel çalışmalar

Doç. Dr. Mesut Ayer

87 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. Real-world effectiveness and safety of fixed-duration frontline venetoclax–obinutuzumab for chronic lymphocytic leukemia: A nationwide multicenter retrospective cohort study

    Leukemia Research, 2026

    DOI 10.1016/j.leukres.2026.108342 PMID 42933070 Kaynak: OpenAlex

  2. Is Baseline PET/CT-Derived Metabolic Tumor Burden Associated with Treatment Response and Survival in Hodgkin Lymphoma?

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15176686 PMID 42739691 Açık erişimli tam metinKaynak: ORCID

  3. Comparative Prognostic Performance of Nutritional Indices in Acute Myeloid Leukemia

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15166179 PMID 42652583 Açık erişimli tam metinKaynak: ORCID

  4. Therapeutic Plasma Exchange Using Membrane Plasma Separation Across a Broad Spectrum of Indications: An Eight-Year Single-Center Retrospective Cohort Study

    International Journal of General Medicine, 2026

    DOI 10.2147/ijgm.s625354 PMID 42670524 Açık erişimli tam metinKaynak: ORCID

  5. Comparative Prognostic Performance of Nutritional and Inflammatory Indices in Diffuse Large B-Cell Lymphoma

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15124703 PMID 42355871 Açık erişimli tam metinKaynak: ORCID

  6. Comparative Prognostic Value of the Durie–Salmon, ISS, and mSMART Staging Systems in Multiple Myeloma

    Eurasian Journal of Medical Advances, 2026

    DOI 10.14744/ejma.268062 Açık erişimli tam metinKaynak: ORCID

  7. NONINVASIVE EVALUATION OF CHORIORETINAL AND PERIPAPILLARY MICROVASCULAR ALTERATIONS IN ESSENTIAL THROMBOCYTHEMIA

    Retina, 2026

    DOI 10.1097/iae.0000000000004757 PMID 41468588 Kaynak: ORCID

  8. Quantitative Assessment of Metabolic Tumor Heterogeneity on Baseline [18F] FDG PET/CT Predicts Prognosis in Hodgkin Lymphoma

    Research Square, 2026

    DOI 10.21203/rs.3.rs-10749019/v1 Açık erişimli tam metinKaynak: ORCID

  9. Publication Only

    HemaSphere, 2026

    DOI 10.1002/hem3.70421 Açık erişimli tam metinKaynak: OpenAlex

  10. Prognostic Value of Baseline ¹⁸F-FDG PET/CT Metabolic Tumor Burden in Multiple Myeloma

    Research Square, 2026

    DOI 10.21203/rs.3.rs-11025606/v1 Açık erişimli tam metinKaynak: OpenAlex

  11. The prognostic value of the HALP score among patients diagnosed with Hodgkin lymphoma

    PubMed Central, 2026

    DOI 10.1097/md.0000000000051347 Açık erişimli tam metinKaynak: OpenAlex

  12. Real-world outcomes and prognostic factors in primary mediastinal B-cell lymphoma: a multicenter study of 157 patients

    Annals of Hematology, 2025

    DOI 10.1007/s00277-025-06644-z PMID 41074982 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  13. Occurrence of Hematological Diseases in Patients with Intraabdominal Venous Thrombosis and Evaluation of Paroxysmal Nocturnal Hemoglobinuria

    Mevlana Medical Sciences, 2025

    DOI 10.56752/mevmedsci.2025.81 Açık erişimli tam metinKaynak: ORCID

  14. Assessment of retinal, choroidal and peripapillary microvascular changes in patients with chronic myeloid leukemia

    Japanese Journal of Ophthalmology, 2025

    DOI 10.1007/s10384-025-01216-0 PMID 40418491 1 atıf (Europe PMC) Kaynak: ORCID

  15. Authors response comments on: Evaluating the impact of polycythemia vera on retinal and optic nerve head microvascularity: An OCTA study

    Indian Journal of Ophthalmology, 2025

    DOI 10.4103/ijo.ijo_2739_24 PMID 40434473 Açık erişimli tam metinKaynak: ORCID

  16. Real-Life Outcomes of Bosutinib in Patients with Chronic Myeloid Leukemia: A Multicenter Nationwide Study from Turkey

    Blood, 2024

    DOI 10.1182/blood-2024-193433 Açık erişimli tam metinKaynak: OpenAlex

  17. Expression patterns of eighteen genes involved in crucial cellular processes in the TP53 pathway in Multiple Myeloma

    Gazi University Journal of Science, 2024

    DOI 10.35378/gujs.1365179 Açık erişimli tam metinKaynak: ORCID

  18. Ascites does not accompany pleural effusion developing under dasatinib therapy in patients with CML-CP

    Pleura and Peritoneum, 2024

    DOI 10.1515/pp-2023-0016 PMID 38558869 3 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  19. Evaluating the impact of polycythemia vera on retinal and optic nerve head microvascularity: An OCTA study

    Indian Journal of Ophthalmology, 2024

    DOI 10.4103/ijo.ijo_1322_24 PMID 39257081 4 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  20. Ineffectiveness of therapeutic plasma exchange as a last resort in severe COVID-19 cases: Experience from a tertiary intensive care unit

    Therapeutic Apheresis and Dialysis, 2024

    DOI 10.1111/1744-9987.14219 PMID 39425626 1 atıf (Europe PMC) Kaynak: ORCID

  21. Management of Adult Primary Immune Thrombocytopenia: DelphiBased Consensus Recommendations

    The Turkish Journal of Hematology, 2024

    DOI 10.4274/tjh.galenos.2024.2024.0055 PMID 38545671 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  22. Management of Primary Immune Thrombocytopenia: Turkish Modified Delphi-Based Consensus Statement for Special Considerations

    The Turkish Journal of Hematology, 2024

    DOI 10.4274/tjh.galenos.2024.2024.0101 PMID 38801066 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  23. Glofitamab in relapsed/refractory diffuse large B‐cell lymphoma: Real‐world data

    Hematological Oncology, 2023

    DOI 10.1002/hon.3174 PMID 37211991 31 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  24. Entecavir‐induced neutropenia in an adult living donor liver transplant recipient: Successful conversion to tenofovir alafenamide

    Clinical Case Reports, 2023

    DOI 10.1002/ccr3.7741 PMID 37575459 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  25. VEXAS syndrome with severe multisystem involvement: Rapid recovery after splenectomy

    International Journal of Rheumatic Diseases, 2023

    DOI 10.1111/1756-185x.14540 PMID 36544349 6 atıf (Europe PMC) Kaynak: ORCID

  26. Evaluation of TMED9, DNAJC1, LMAN2, COPE and KDELR1 Biomarkers in Patients with Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

    UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi, 2023

    DOI 10.4999/uhod.236990 Kaynak: ORCID

  27. Retrospective analysis of respiratory virus infections in adults with hematologic malignancies

    European Review for Medical and Pharmacological Sciences, 2023

    DOI 10.26355/eurrev_202311_34358 PMID 37975403 1 atıf (OpenAlex) Kaynak: ORCID

  28. The Relationship of Tc-99m Pyp Scintigraphy Parameters with Prognosis and Life Expectation in Cardiac Amiloidosis

    European Journal of Nuclear Medicine and Molecular Imaging, 2023

    Kaynak: ORCID

  29. Visceral leishmaniasis in a patient with systemic lupus erythematosus: Dilemma in diagnosis and management

    International Journal of Rheumatic Diseases, 2023

    DOI 10.1111/1756-185x.14510 PMID 36502503 1 atıf (Europe PMC) Kaynak: ORCID

  30. Could “Islets of Sparing” Be a Clue for Neutral Lipid Storage Disease with Ichthyosis in Patients with Congenital Ichthyosiform Erythroderma?

    Indian Journal of Dermatology, 2022

    DOI 10.4103/ijd.ijd_1154_20 PMID 36865854 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  31. CD5 as a prognostic marker in patients with diffuse large B-cell lymphoma: a multicenter study

    Journal of Hematopathology, 2022

    DOI 10.1007/s12308-022-00523-6 3 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  32. TMED9 is a Predictive Marker of Transition from Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

    Research Square, 2022

    DOI 10.21203/rs.3.rs-2370302/v1 Açık erişimli tam metinKaynak: OpenAlex

  33. SPONTANEOUS GASTROSPLENIC FISTULA: AN UNUSUAL PRESENTATION OF DIFFUSE LARGE B CELL LYMPHOMA

    Gastroenterology Nursing, 2022

    DOI 10.1097/sga.0000000000000637 PMID 35020633 2 atıf (OpenAlex) Kaynak: OpenAlex

  34. Treatment of COVID-19-Releated Hyperinflammatory Response In Intensive Care Unit: Pulse Steroid, Anticytokines, IVIG, Plasmapheresis.

    Journal of Contemporary Medicine, 2022

    DOI 10.16899/jcm.1030022 Açık erişimli tam metinKaynak: ORCID

  35. Case of Olmsted Syndrome with Essential Thrombocytosis Misdiagnosed as Acrodermatitis Enteropathica.

    PubMed Central, 2021

    DOI 10.4103/ijd.ijd_595_20 PMID 35068533 Açık erişimli tam metinKaynak: OpenAlex

  36. Evaluation of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in Turkey: a multicenter retrospective analysis.

    PubMed Central, 2021

    PMID 34322292 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  37. Dysregulation of MS4A3 and PRDX5 Gene Expression in Multiple Myeloma Patients

    UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi, 2021

    DOI 10.4999/uhod.215420 3 atıf (OpenAlex) Kaynak: ORCID

  38. The impact of transfusion burden and comorbidities on the prognosis of patients with myelodysplastic syndromes

    Transfusion and Apheresis Science, 2020

    DOI 10.1016/j.transci.2020.102845 PMID 32591291 3 atıf (Europe PMC) Kaynak: ORCID

  39. A multi-centric study on the efficacy of eltrombopag in management of refractory chronic immune thrombocytopenia

    Turkish Journal of Hematology, 2019

    DOI 10.4274/tjh.galenos.2019.2018.0307 PMID 31327186 15 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  40. Evaluation of Patients with PNH Treated By Eculizumab: Real World Data from Turkey

    Blood, 2019

    DOI 10.1182/blood-2019-128743 Açık erişimli tam metinKaynak: OpenAlex

  41. Treatment modalities of non-Hodgkin lymphoma patients over 65 years of age: A two-center experience.

    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2019

    DOI 10.1177/1078155219839460 PMID 30924740 1 atıf (Europe PMC) Kaynak: ORCID

  42. A rare case of newly diagnosed multiple myeloma presenting to the emergency department with acute paraplegias

    Journal of Surgery and Medicine, 2019

    DOI 10.28982/josam.652699 Açık erişimli tam metinKaynak: ORCID

  43. Investigation of Gene Expressions of Myeloma Cells in the Bone Marrow of Multiple Myeloma Patients by Transcriptome Analysis

    Balkan Medical Journal, 2019

    DOI 10.4274/balkanmedj.2018.0356 PMID 30079703 12 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  44. Multisystem involvement of Langerhans cell histiocytosis in an adult

    Indian Journal of Medical Research, 2019

    DOI 10.4103/ijmr.ijmr_1726_17 PMID 31115382 Açık erişimli tam metinKaynak: ORCID

  45. Evaluation of Hypogammaglobulinemia in Chronic Lymphocytic Leukemia Patients and Its Relation to Poor Prognostic Factors

    Medical Bulletin of Haseki, 2018

    DOI 10.4274/haseki.85057 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

  46. Frequency of Paroxysmal Nocturnal Hemoglobinuria Clone in Turkish Myelodysplastic Syndrome Group

    Medical Bulletin of Haseki, 2018

    DOI 10.4274/haseki.40327 Açık erişimli tam metinKaynak: ORCID

  47. Investigation of ErbB and Insulin Signaling Pathways in the Pathogenesis of Multiple Myeloma

    The Medical Bulletin of Haseki, 2018

    DOI 10.4274/haseki.30502 Açık erişimli tam metinKaynak: ORCID

  48. The Prevalence of Paroxysmal Nocturnal Hemoglobinuria Clone in Adult Patients with Idiopathic Pulmonary Hypertension

    The Medical Bulletin of Haseki, 2018

    DOI 10.4274/haseki.73745 Açık erişimli tam metinKaynak: ORCID

  49. Paroxysmal Nocturnal Haemoglobinuria Presenting with Acute Kidney Injury: A Case Report

    The Medical Journal of Okmeydani Training and Research Hospital, 2017

    DOI 10.5222/otd.2017.1105 Kaynak: OpenAlex

  50. Akut Böbrek Hasarı ile Prezente Olan Paroksismal Nokturnal Hemoglobinüri

    The Medical Journal of Okmeydani Training and Research Hospital, 2017

    Kaynak: OpenAlex